Klaas Financial Asset Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-50
Closed -$2K 80
2021
Q4
$2K Hold
50
﹤0.01% 85
2021
Q3
$2K Hold
50
﹤0.01% 80
2021
Q2
$2K Buy
+50
New +$1.65K ﹤0.01% 86

Other funds holding OGN

Klaas Financial Asset Advisors's OGN Position: Q1 2022 in Review

Klaas Financial Asset Advisors sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 50 shares — an estimated $2K sold.

Klaas Financial Asset Advisors first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $2K in Q4 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

  • Klaas Financial Asset Advisors reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
  • Klaas Financial Asset Advisors sold 50 Organon & Co shares in Q1 2022, an estimated $2K.
  • Klaas Financial Asset Advisors first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
  • Klaas Financial Asset Advisors's Organon & Co position peaked at $2K in Q4 2021.
  • 818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Klaas Financial Asset Advisors's 13F filing for Q1 2022, filed 13 May 2022.